Image source: The Motley Fool. Radware Ltd. (NASDAQ:RDWR) delivered record financial results, closing the period with double-digit percentage growth in revenue, earnings, and recurring metrics.

Key Points Interested in JOYY Inc.? Here are five stocks we like better. JOYY posted strong Q1 2026 results, with total net revenue up 12.4% year over year to $555.7 million and non-GAAP ...

National Vision Holdings Inc (EYE) reports a 6.6% revenue increase and strategic military expansion, despite challenges in customer traffic and online integration.

Personalized algorithms may quietly sabotage how people learn, nudging them into narrow tunnels of information even when they start with zero prior knowledge. In the study, participants using ...

Earnings call Dave delivered a strong Q1 2026 with revenue up 47% YoY to $158.4M and adjusted EBITDA up 57% to $69.3M (44% margin). Management raised full-year guidance across revenue ($710M–$720M), ...

JERUSALEM, April 29 (Reuters) - New maps of Gaza quietly issued by Israel a little more than a month ago have put thousands of displaced Palestinians inside an expanded restricted area, within ...

Insomniac’s Countdown NYE will return to Southern California this year with an expanded format. The New Year’s Eve electronic music festival is scheduled for Dec. 31 and Jan. 1 at the NOS Event Center ...

Adam Silver and the NBA’s quixotic quest to end tanking reached a new level of complexity on Tuesday when the league unveiled a new plan to the 30 league GMs on a conference call. This new “3-2-1" ...

It's been only a few months since OpenAI released its last big improvement to AI image generations in ChatGPT and through its application programming interface (API) — namely, a new image generation ...

LINCOLN, Neb. (Nebraska Today) - The University of Nebraska–Lincoln is reimagining one of its busiest campus hubs, expanding the Nebraska Union dining area with new restaurant concepts, more variety ...

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers newer diabetes medications, comorbidities, and — for the first time — ...